Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
4D Molecular Therapeutics, Inc. | President and COO | Stock Option (Right to Buy) | 260K | Dec 11, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
FDMT | 4D Molecular Therapeutics, Inc. | Dec 11, 2023 | 1 | $0 | 4 | Dec 13, 2023 | President and COO |
FDMT | 4D Molecular Therapeutics, Inc. | Feb 10, 2023 | 1 | $0 | 4 | Feb 14, 2023 | President & COO |
FDMT | 4D Molecular Therapeutics, Inc. | Sep 23, 2022 | 1 | $0 | 4 | Sep 27, 2022 | President & COO |
FDMT | 4D Molecular Therapeutics, Inc. | Sep 1, 2022 | 1 | $0 | 4 | Sep 6, 2022 | Chief Operating Officer, Chief Technical Officer |
FDMT | 4D Molecular Therapeutics Inc. | Feb 1, 2022 | 1 | $0 | 4 | Feb 3, 2022 | Chief Operating Officer, Chief Technical Officer |